Statistical analysis of clinical and laboratory data (WP5)
- Workpackage leader
- Objectives of the Workpackage
- To characterise changes over time of tissue damage biomarkers in GVHD patients following Treg-based therapies.
- To investigate the associations between time-dependent tissue damage biomarkers and clinical data.
- To identify both clinical and biological predictors of response to therapy (i.e. complete response, partial response, non-responders, progressive disease)